Clinical Trial for Hepatocellular Carcinoma
Last Updated on 4/16/2012 2:42:06 PM
to honor a cholangiocarcinoma patient will be held on Monday, May 21, 2012.
Collaboration: Secrets of Success
Living Longer Than Predicted
High-resolution characterization of a hepatocellular carcinoma genome
Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular Carcinoma
Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma
TACE and Sorafenib: A Good Marriage?
April 18-22, 2012
Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.
Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study.